Causal association of circulating immune cells and lymphoma: A Mendelian randomization study
Wang Feixiang,
Huang Guoxin,
Luo Yuqing,
Xiong Kaixin,
Liu Ying,
Wang Yao
Affiliations
Wang Feixiang
Medical Oncology Department, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong, Guangzhou, 510095, China
Huang Guoxin
Department of Evidence-Based Medicine Center, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, China
Luo Yuqing
Medical Oncology Department, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong, Guangzhou, 510095, China
Xiong Kaixin
Medical Oncology Department, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong, Guangzhou, 510095, China
Liu Ying
Department of Evidence-Based Medicine Center, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, No. 15, Jiefang Road, Xiangyang, Hubei, 441000, China
Wang Yao
Medical Oncology Department, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No. 78, Hengzhigang, Yuexiu District, Guangdong, Guangzhou, 510095, China
Malignant lymphoma (ML) is a group of malignant tumors originating from the lymphatic hematopoietic system. Previous studies have found a correlation between circulating immune cells and ML. Nonetheless, the precise influence of circulating immune cells on ML remains uncertain.
